Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: A preliminary report-Reference-Cited by-同舟云学术

Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: A preliminary report

Published:1991-12 Issue:6 Volume:165 Page:1806-1810
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Cassidenti Denise L.,Sauer Mark V.,Paulson Richard J.,Ditkoff Edward C.,Rivier Jean,Yen Samuel S.C.,Lobo Rogerio A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference18 articles.

1. Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins;Awadalla;Fertil Steril,1987

2. Evidence supporting the routine use of a GnRH agonist (GnRH-a) during ovarian stimulation for in vitro fertilization (IVF) [Abstract];Anderson,1988

3. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval;Meldrum;Fertil Steril,1989

4. Suppression of the ovary using a gonadotropin-releasing hormone agonist prior to stimulation for oocyte retrieval;de Ziegler;Fertil Steril,1987

5. Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy;Feldberg;Fertil Steril,1989

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-Dependent Chlormadinone Acetate Can Suppress Premature LH Surge in Parallel with LH Value Reduction;Fertility & Reproduction;2020-03

2. In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle;Fertility and Sterility;2011-06

3. Does premature luteinization or early surge of LH impair cycle outcome? Report of two successful outcomes;Journal of Assisted Reproduction and Genetics;2009-02-18

4. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists;Fertility and Sterility;2004-07

5. Use of Gonadotrophin Releasing Hormone (GnRH) Antagonist (Cetrotide) during Ovarian Stimulation for in-vitro Fertilization Treatment: Multiple Doses and Single Dose;Journal of Obstetrics and Gynaecology Research;2001-10